Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
3
4
Next >
Johnson & Johnson Reports Q4 and Full-Year 2024 Results
January 22, 2025
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
From
Johnson & Johnson
Via
Business Wire
Tickers
ITCI
JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
January 02, 2025
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 12, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 10, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
October 15, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q3 2024 Results
October 15, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Stifel 2024 Healthcare Conference
October 10, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of V-Wave
October 09, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
October 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces that its Subsidiary, Red River Talc LLC, has Filed a Voluntary Prepackaged Chapter 11 Case to Resolve All Current and Future Ovarian Cancer Talc Claims
September 20, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 05, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024
August 26, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire V-Wave
August 20, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
July 29, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
July 23, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q2 2024 results
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
July 11, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
June 21, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Shockwave Medical
May 31, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
May 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
May 01, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
April 22, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
April 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today